Literature DB >> 29549225

Temporal trends in multiple sclerosis prevalence and incidence in a large population.

Dalia L Rotstein1, Hong Chen2, Andrew S Wilton2, Jeffrey C Kwong2, Ruth Ann Marrie2, Peter Gozdyra2, Kristen M Krysko2, Alexander Kopp2, Ray Copes2, Karen Tu2.   

Abstract

OBJECTIVE: We sought to better understand the reasons for increasing prevalence of multiple sclerosis (MS) by studying prevalence in relation to incidence, mortality rates, sex ratio, and geographic distribution of cases.
METHODS: We identified MS cases from 1996 to 2013 in Ontario, Canada, by applying a validated algorithm to health administrative data. We calculated age- and sex-standardized prevalence and incidence rates for the province and by census division. Incidence and prevalence sex ratios for women to men were computed.
RESULTS: The prevalence of MS increased by 69% from 1.57 (95% confidence interval [CI]: 1.54-1.59) per 1,000 in 1996 (n = 12,155) to 2.65 (95% CI: 2.62-2.68) in 2013 (n = 28,192). Incidence remained relatively stable except for a spike in 2010, followed by a subsequent decline in 2011-2013, particularly among young people and men. Mortality decreased by 33% from 26.7 (95% CI: 23.5-30.3) per 1,000 to 18.0 (95% CI: 16.4-19.8) per 1,000. The incidence sex ratio was stable from 1996 to 2009, then declined in 2010, with partial rebound by 2013. MS prevalence and incidence showed no consistent association with latitude.
CONCLUSION: In this large, population-based MS cohort, we found stable incidence and increasing prevalence of MS; the latter largely reflected declining mortality. A spike in incidence in 2010 among younger patients and men at a time of widespread media coverage of MS suggests that these groups may be vulnerable to delayed diagnosis. We did not find a latitudinal gradient; however, most Ontarians live between the 42nd and 46th parallels, reducing our ability to detect an effect of latitude.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Year:  2018        PMID: 29549225     DOI: 10.1212/WNL.0000000000005331

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  MS risk in immigrants in the McDonald era: A population-based study in Ontario, Canada.

Authors:  Dalia L Rotstein; Ruth Ann Marrie; Colleen Maxwell; Sima Gandhi; Susan E Schultz; Kinwah Fung; Karen Tu
Journal:  Neurology       Date:  2019-11-05       Impact factor: 9.910

Review 2.  Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases.

Authors:  Erkan Kiris
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern.

Authors:  Blaine Caslin; Cole Maguire; Aditi Karmakar; Kailey Mohler; Dennis Wylie; Esther Melamed
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-02       Impact factor: 11.205

Review 4.  Sex differences in autoimmune disorders of the central nervous system.

Authors:  Stefan M Gold; Anne Willing; Frank Leypoldt; Friedemann Paul; Manuel A Friese
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

Review 5.  Epidemiology and treatment of multiple sclerosis in elderly populations.

Authors:  Caila B Vaughn; Dejan Jakimovski; Katelyn S Kavak; Murali Ramanathan; Ralph H B Benedict; Robert Zivadinov; Bianca Weinstock-Guttman
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

6.  Clinical characteristics of a large multi-center cohort of people with multiple sclerosis over age 60.

Authors:  Le H Hua; Carrie M Hersh; Fan Tian; Ellen M Mowry; Kathryn C Fitzgerald
Journal:  Mult Scler Relat Disord       Date:  2020-11-23       Impact factor: 4.339

Review 7.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

8.  High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.

Authors:  Ruth Ann Marrie; Julia O'Mahony; Colleen J Maxwell; Vicki Ling; E Ann Yeh; Douglas L Arnold; Amit Bar-Or; Brenda Banwell
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

9.  Prevalence of multiple sclerosis in Cuenca, Ecuador.

Authors:  Edgar Patricio Correa-Díaz; María Angélica Ortiz; Ana María Toral; Fernando Guillen; Enrique Terán; Daniel Ontaneda; María García-Castillo; Carolina Jácome-Sánchez; Germaine Torres-Herrán; Andrés Ortega-Heredia; María Eugenia Buestán; Juan Murillo-Calle; Praneeta Raza; Guillermo Baño
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-10-30

10.  Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple Sclerosis.

Authors:  Vittoria Borgonetti; Maria Domenica Sanna; Laura Lucarini; Nicoletta Galeotti
Journal:  Neurotherapeutics       Date:  2020-11-16       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.